SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 09/17/2025 at 07:00, 1 year 1 month ago

Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
Sanofi's brivekimig shows positive results in phase 2a study for hidradenitis suppurativa, presenting clinically meaningful improvements in primary and secondary endpoints in biologic-naïve patients

Sanofi Brivekimig Hidradenitis Suppurativa Phase 2a Study Immune-mediated Diseases
PRESS RELEASE

published on 09/15/2025 at 18:30, 1 year 1 month ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 09/12/2025 at 18:35, 1 year 1 month ago

Sanofi Publishes Voting Rights Data for August 2025

Voting Rights Actions Financial Markets Sanofi August 2025
PRESS RELEASE

published on 09/12/2025 at 18:30, 1 year 1 month ago

Sanofi: Information concerning the total number of voting rights and shares - August 2025
Sanofi discloses total number of voting rights and shares as per French regulations. Details available on Sanofi's website

Voting Rights Shares French Regulations Disclosure Sanofi
BRIEF

published on 09/11/2025 at 07:05, 1 year 1 month ago

Sanofi Obtains Fast Track Designation for SAR402663 in the United States

FDA Gene Therapy Sanofi Fast Track AMD
BRIEF

published on 08/29/2025 at 23:55, 1 year 2 months ago

Sanofi’s Wayrilz Gets FDA Approval as First BTK Inhibitor for ITP

FDA Approval Sanofi BTK Inhibitor Wayrilz Immune Thrombocytopenia
PRESS RELEASE

published on 08/29/2025 at 23:50, 1 year 2 months ago

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
Sanofi's Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia. Novel treatment targets BTK through multi-immune modulation to address root causes of ITP, providing rapid and durable platelet response and improved symptoms

Sanofi BTK Inhibitor Wayrilz Immune Thrombocytopenia LUNA 3 Study
PRESS RELEASE

published on 08/25/2025 at 18:30, 1 year 2 months ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 08/18/2025 at 18:35, 1 year 2 months ago

Sanofi Reports Total Shares and Voting Rights for July 2025

Voting Rights French Commercial Code Shares 2025 Sanofi
PRESS RELEASE

published on 08/18/2025 at 18:30, 1 year 2 months ago

Sanofi: Information concerning the total number of voting rights and shares - July 2025
Sanofi discloses total voting rights and issued shares as per French commercial and stock market regulations. Details available on their website

Voting Rights Shares French Regulations Investor Relations Sanofi

Published on 11/02/2026 at 16:15, 54 minutes ago

ACCESS Newswire Launches SPOT, Seven AI Agents That Check Every Press Release Before Submission
Published on 11/02/2026 at 15:00, 2 hours 9 minutes ago

CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
Published on 11/02/2026 at 14:00, 3 hours 9 minutes ago

GameSquare to Report Q3 2026 Financial Results on November 16, 2026
Published on 11/02/2026 at 14:00, 3 hours 9 minutes ago

Tectonic Metals Intersects 5.61 g/t Au Over 41.15 m, Including 12.94 g/t Au Over 13.72 m, Within 2.86 g/t Au Over 91.44 m, Strengthening Evidence for a Second Gold System at the Flat Gold Project
Published on 11/02/2026 at 13:30, 3 hours 39 minutes ago

Electric Metals (USA) Limited Announces Results of Annual Meeting of Stockholders

View all ACCESSWIRE

Published on 11/02/2026 at 16:00, 1 hour 9 minutes ago

Shares Admitted to Trading and Total Voting Rights
Published on 11/02/2026 at 15:58, 1 hour 11 minutes ago

Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy
Published on 11/02/2026 at 15:19, 1 hour 50 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 11/02/2026 at 15:19, 1 hour 50 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 11/02/2026 at 15:18, 1 hour 51 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc

View all EQS

Published on 11/02/2026 at 15:25, 1 hour 44 minutes ago

Guillemot Corporation S.A. | Information regarding the total number of voting rights and shares 31/10/2026
Published on 10/30/2026 at 23:00, 2 days 18 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days 20 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 23 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 3 days 5 hours ago

Capital increase through exercise of subscription rights

View all LES ECHOS COMFI WIRE

News